Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
David Goldenberg
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Chemicals & Drugs
Procedures
Living Beings
Disorders
Concepts & Ideas
Anatomy
Sign-in to see full Profile
Network (preview)
143
Sharkey, Robert
80
Hansen, Hans
59
Blumenthal, Rosalyn
38
Griffiths, Gary
37
Mattes, Jules
29
Juweid, ME
28
Stein, Rhona
27
Karacay, Habibe
25
Govindan, Serengulam
22
Shih, LB
20
Behr, Thomas
19
Horak, Ivan
18
Cardillo, Thomas
17
McBride, William
16
Siegel, Jeffry
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of David Goldenberg (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Govindan Serengulam V; Cardillo Thomas M; Moon Sung-Ju; Hansen Hans J; Goldenberg David M
CEACAM5-targeted therapy of human colonic and pancreatic cancer xenografts with potent labetuzumab-SN-38 immunoconjugates.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(19):6052-61.
-
2009: Kraeber-Bodéré F; Goldenberg D M; Chatal J F; Barbet J
Pretargeted radioimmunotherapy in the treatment of metastatic medullary thyroid cancer.
Current oncology (Toronto, Ont.) 2009;16(5):3-8.
-
2009: Modrak David E; Leon Evelyn; Goldenberg David M; Gold David V
Ceramide regulates gemcitabine-induced senescence and apoptosis in human pancreatic cancer cell lines.
Molecular cancer research : MCR 2009;7(6):890-6.
-
2009: Mattes M Jules; Michel Rosana B; Goldenberg David M; Sharkey Robert M
Induction of apoptosis by cross-linking antibodies bound to human B-lymphoma cells: expression of Annexin V binding sites on the antibody cap.
Cancer biotherapy & radiopharmaceuticals 2009;24(2):185-93.
-
2009: Sharkey Robert M; Press Oliver W; Goldenberg David M
A re-examination of radioimmunotherapy in the treatment of non-Hodgkin lymphoma: prospects for dual-targeted antibody/radioantibody therapy.
Blood 2009;113(17):3891-5.
-
2009: Sharkey Robert M; Karacay Habibe; Johnson Christine R; Litwin Samuel; Rossi Edmund A; McBride William J; Chang Chien-Hsing; Goldenberg David M
Pretargeted versus directly targeted radioimmunotherapy combined with anti-CD20 antibody consolidation therapy of non-Hodgkin lymphoma.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2009;50(3):444-53.
-
2009: Goldenberg David M; Rossi Edmund A; Stein Rhona; Cardillo Thomas M; Czuczman Myron S; Hernandez-Ilizaliturri Francisco J; Hansen Hans J; Chang Chien-Hsing
Properties and structure-function relationships of veltuzumab (hA20), a humanized anti-CD20 monoclonal antibody.
Blood 2009;113(5):1062-70.
-
2008: Moon Sung-Ju; Govindan Serengulam V; Cardillo Thomas M; D'Souza Christopher A; Hansen Hans J; Goldenberg David M
Antibody conjugates of 7-ethyl-10-hydroxycamptothecin (SN-38) for targeted cancer chemotherapy.
Journal of medicinal chemistry 2008;51(21):6916-26.
-
2008: Leonard John P; Schuster Stephen J; Emmanouilides Christos; Couture Felix; Teoh Nick; Wegener William A; Coleman Morton; Goldenberg David M
Durable complete responses from therapy with combined epratuzumab and rituximab: final results from an international multicenter, phase 2 study in recurrent, indolent, non-Hodgkin lymphoma.
Cancer 2008;113(10):2714-23.
-
2008: Sharkey Robert M; Goldenberg David M
Use of antibodies and immunoconjugates for the therapy of more accessible cancers.
Advanced drug delivery reviews 2008;60(12):1407-20.
-
2008: Sharkey Robert M; Karacay Habibe; Litwin Samuel; Rossi Edmund A; McBride William J; Chang Chien-Hsing; Goldenberg David M
Improved therapeutic results by pretargeted radioimmunotherapy of non-Hodgkin's lymphoma with a new recombinant, trivalent, anti-CD20, bispecific antibody.
Cancer research 2008;68(13):5282-90.
-
2008: Mattes M Jules; Goldenberg David M
Therapy of human carcinoma xenografts with antibodies to EGFr and HER-2 conjugated to radionuclides emitting low-energy electrons.
European journal of nuclear medicine and molecular imaging 2008;35(7):1249-58.
-
2008: Gold David V; Goldenberg David M; Karacay Habibe; Rossi Edmund A; Chang Chien-Hsing; Cardillo Thomas M; McBride William J; Sharkey Robert M
A novel bispecific, trivalent antibody construct for targeting pancreatic carcinoma.
Cancer research 2008;68(12):4819-26.
-
2008: Bodet-Milin Caroline; Kraeber-Bodéré Françoise; Dupas Benoît; Morschhauser Franck; Gastinne Thomas; Le Gouill Steven; Campion Loïc; Harousseau Jean-Luc; Wegener William A; Goldenberg David M; Huglo Damien
Evaluation of response to fractionated radioimmunotherapy with 90Y-epratuzumab in non-Hodgkin's lymphoma by 18F-fluorodeoxyglucose positron emission tomography.
Haematologica 2008;93(3):390-7.
-
2008: Sharkey Robert M; Karacay Habibe; Vallabhajosula Shankar; McBride William J; Rossi Edmund A; Chang Chien-Hsing; Goldsmith Stanley J; Goldenberg David M
Metastatic human colonic carcinoma: molecular imaging with pretargeted SPECT and PET in a mouse model.
Radiology 2008;246(2):497-507.
-
2008: Goldenberg David M; Rossi Edmund A; Sharkey Robert M; McBride William J; Chang Chien-Hsing
Multifunctional antibodies by the Dock-and-Lock method for improved cancer imaging and therapy by pretargeting.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2008;49(1):158-63.
-
2007: Gold David V; Karanjawala Zarir; Modrak David E; Goldenberg David M; Hruban Ralph H
PAM4-reactive MUC1 is a biomarker for early pancreatic adenocarcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(24):7380-7.
-
2007: Chang Chien-Hsing; Rossi Edmund A; Goldenberg David M
The dock and lock method: a novel platform technology for building multivalent, multifunctional structures of defined composition with retained bioactivity.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(18 Pt 2):5586s-5591s.
-
2007: Sharkey Robert M; Karacay Habibe; McBride William J; Rossi Edmund A; Chang Chien-Hsing; Goldenberg David M
Bispecific antibody pretargeting of radionuclides for immuno single-photon emission computed tomography and immuno positron emission tomography molecular imaging: an update.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(18 Pt 2):5577s-5585s.
-
2007: Brard Pierre-Yves; Karacay Habibe; Stein Rhona; Sharkey Robert M; Mattes M Jules; Chang Chien-Hsing; Rossi Edmund A; McBride William J; Goldenberg David M
A divalent hapten-peptide induces apoptosis in human non hodgkin lymphoma cell lines targeted by anti-CD20xanti-hapten bispecific antibodies.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(18 Pt 2):5564s-5571s.
-
2007: Stein Rhona; Mattes M Jules; Cardillo Thomas M; Hansen Hans J; Chang Chien-Hsing; Burton Jack; Govindan Serengulam; Goldenberg David M
CD74: a new candidate target for the immunotherapy of B-cell neoplasms.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(18 Pt 2):5556s-5563s.
-
2007: Liersch Torsten; Meller Johannes; Bittrich Michael; Kulle Bettina; Becker Heinz; Goldenberg David M
Update of carcinoembryonic antigen radioimmunotherapy with (131)I-labetuzumab after salvage resection of colorectal liver metastases: comparison of outcome to a contemporaneous control group.
Annals of surgical oncology 2007;14(9):2577-90.
-
2007: Burton Jack D; Castillo Mary E; Goldenberg David M; Blumenthal Rosalyn D
Peroxisome proliferator-activated receptor-gamma antagonists exhibit potent antiproliferative effects versus many hematopoietic and epithelial cancer cell lines.
Anti-cancer drugs 2007;18(5):525-34.
-
2007: Goldenberg D M; Sharkey R M
Novel radiolabeled antibody conjugates.
Oncogene 2007;26(25):3734-44.
-
2007: Blumenthal Rosalyn D; Goldenberg David M
Methods and goals for the use of in vitro and in vivo chemosensitivity testing.
Molecular biotechnology 2007;35(2):185-97.
-
2007: Taylor Alice P; Goldenberg David M
Role of placenta growth factor in malignancy and evidence that an antagonistic PlGF/Flt-1 peptide inhibits the growth and metastasis of human breast cancer xenografts.
Molecular cancer therapeutics 2007;6(2):524-31.
-
2007: Carnahan Josette; Stein Rhona; Qu Zhengxing; Hess Kristen; Cesano Alessandra; Hansen Hans J; Goldenberg David M
Epratuzumab, a CD22-targeting recombinant humanized antibody with a different mode of action from rituximab.
Molecular immunology 2007;44(6):1331-41.
-
2007: Blumenthal Rosalyn D; Leon Evelyn; Hansen Hans J; Goldenberg David M
Expression patterns of CEACAM5 and CEACAM6 in primary and metastatic cancers.
BMC cancer 2007;7():2.
-
2006: Goldenberg D M; Sharkey R M
Advances in cancer therapy with radiolabeled monoclonal antibodies.
The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of Radiopharmaceutical Chemistry and Biology 2006;50(4):248-64.
-
2006: Goldenberg David M
Adjuvant and combined radioimmunotherapy: problems and prospects on the road to Minerva.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2006;47(11):1746-8.
-
2006: Goldenberg David M
Epratuzumab in the therapy of oncological and immunological diseases.
Expert review of anticancer therapy 2006;6(10):1341-53.
-
2006: McBride William J; Zanzonico Pat; Sharkey Robert M; Norén Carl; Karacay Habibe; Rossi Edmund A; Losman Michele J; Brard Pierre-Yves; Chang Chien-Hsing; Larson Steven M; Goldenberg David M
Bispecific antibody pretargeting PET (immunoPET) with an 124I-labeled hapten-peptide.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2006;47(10):1678-88.
-
2006: Stein Rhona; Qu Zhengxing; Chen Susan; Solis David; Hansen Hans J; Goldenberg David M
Characterization of a humanized IgG4 anti-HLA-DR monoclonal antibody that lacks effector cell functions but retains direct antilymphoma activity and increases the potency of rituximab.
Blood 2006;108(8):2736-44.
-
2006: Sharkey Robert M; Goldenberg David M
Targeted therapy of cancer: new prospects for antibodies and immunoconjugates.
CA: a cancer journal for clinicians 2006;56(4):226-43.
-
2006: Modrak David E; Gold David V; Goldenberg David M
Sphingolipid targets in cancer therapy.
Molecular cancer therapeutics 2006;5(2):200-8.
-
2006: Sharkey Robert M; Goldenberg David M
Advances in radioimmunotherapy in the age of molecular engineering and pretargeting.
Cancer investigation 2006;24(1):82-97.
-
2006: Kraeber-Bodéré Françoise; Rousseau Caroline; Bodet-Milin Caroline; Ferrer Ludovic; Faivre-Chauvet Alain; Campion Loïc; Vuillez Jean-Philippe; Devillers Anne; Chang Chien-Hsing; Goldenberg David M; Chatal Jean-François; Barbet Jacques
Targeting, toxicity, and efficacy of 2-step, pretargeted radioimmunotherapy using a chimeric bispecific antibody and 131I-labeled bivalent hapten in a phase I optimization clinical trial.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2006;47(2):247-55.
-
2006: Goldenberg David M; Sharkey Robert M; Paganelli Giovanni; Barbet Jacques; Chatal Jean-François
Antibody pretargeting advances cancer radioimmunodetection and radioimmunotherapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(5):823-34.
-
2006: Gold David V; Modrak David E; Ying Zhiliang; Cardillo Thomas M; Sharkey Robert M; Goldenberg David M
New MUC1 serum immunoassay differentiates pancreatic cancer from pancreatitis.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(2):252-8.
-
2005: Chang Chien-Hsing; Sapra Puja; Vanama Sailaja S; Hansen Hans J; Horak Ivan D; Goldenberg David M
Effective therapy of human lymphoma xenografts with a novel recombinant ribonuclease/anti-CD74 humanized IgG4 antibody immunotoxin.
Blood 2005;106(13):4308-14.
-
2005: Karacay Habibe; Brard Pierre-Yves; Sharkey Robert M; Chang Chien-Hsing; Rossi Edmund A; McBride William J; Ragland Dan R; Horak Ivan D; Goldenberg David M
Therapeutic advantage of pretargeted radioimmunotherapy using a recombinant bispecific antibody in a human colon cancer xenograft.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(21):7879-85.
-
2005: Sharkey Robert M; Cardillo Thomas M; Rossi Edmund A; Chang Chien-Hsing; Karacay Habibe; McBride William J; Hansen Hans J; Horak Ivan D; Goldenberg David M
Signal amplification in molecular imaging by pretargeting a multivalent, bispecific antibody.
Nature medicine 2005;11(11):1250-5.
-
2005: Blumenthal Rosalyn D; Hansen Hans J; Goldenberg David M
Inhibition of adhesion, invasion, and metastasis by antibodies targeting CEACAM6 (NCA-90) and CEACAM5 (Carcinoembryonic Antigen).
Cancer research 2005;65(19):8809-17.
-
2005: Rossi Edmund A; Chang Chien-Hsing; Losman Michele J; Sharkey Robert M; Karacay Habibe; McBride William; Cardillo Thomas M; Hansen Hans J; Qu Zhengxing; Horak Ivan D; Goldenberg David M
Pretargeting of carcinoembryonic antigen-expressing cancers with a trivalent bispecific fusion protein produced in myeloma cells.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(19 Pt 2):7122s-7129s.
-
2005: Sharkey Robert M; Karacay Habibe; Cardillo Thomas M; Chang Chien-Hsing; McBride William J; Rossi Edmund A; Horak Ivan D; Goldenberg David M
Improving the delivery of radionuclides for imaging and therapy of cancer using pretargeting methods.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(19 Pt 2):7109s-7121s.
-
2005: Liersch Torsten; Meller Johannes; Kulle Bettina; Behr Thomas M; Markus Peter; Langer Claus; Ghadimi B Michael; Wegener William A; Kovacs Jacqueline; Horak Ivan D; Becker Heinz; Goldenberg David M
Phase II trial of carcinoembryonic antigen radioimmunotherapy with 131I-labetuzumab after salvage resection of colorectal metastases in the liver: five-year safety and efficacy results.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(27):6763-70.
-
2005: Govindan Serengulam V; Griffiths Gary L; Hansen Hans J; Horak Ivan D; Goldenberg David M
Cancer therapy with radiolabeled and drug/toxin-conjugated antibodies.
Technology in cancer research & treatment 2005;4(4):375-91.
-
2005: Leonard John P; Coleman Morton; Ketas Jamie; Ashe Michelle; Fiore Jennifer M; Furman Richard R; Niesvizky Ruben; Shore Tsiporah; Chadburn Amy; Horne Heather; Kovacs Jacqueline; Ding Cliff L; Wegener William A; Horak Ivan D; Goldenberg David M
Combination antibody therapy with epratuzumab and rituximab in relapsed or refractory non-Hodgkin's lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(22):5044-51.
-
2005: Mirallié Eric; Saï-Maurel Catherine; Faivre-Chauvet Alain; Regenet Nicolas; Chang Chien-Hsing; Goldenberg David M; Chatal Jean-François; Barbet Jacques; Thedrez Philippe
Improved pretargeted delivery of radiolabelled hapten to human tumour xenograft in mice by avidin chase of circulating bispecific antibody.
European journal of nuclear medicine and molecular imaging 2005;32(8):901-9.
-
2005: Sapra Puja; Stein Rhona; Pickett Jennifer; Qu Zhengxing; Govindan Serengulam V; Cardillo Thomas M; Hansen Hans J; Horak Ivan D; Griffiths Gary L; Goldenberg David M
Anti-CD74 antibody-doxorubicin conjugate, IMMU-110, in a human multiple myeloma xenograft and in monkeys.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(14):5257-64.
-
2005: Lindén Ola; Hindorf Cecilia; Cavallin-Ståhl Eva; Wegener William A; Goldenberg David M; Horne Heather; Ohlsson Tomas; Stenberg Lars; Strand Sven-Erik; Tennvall Jan
Dose-fractionated radioimmunotherapy in non-Hodgkin's lymphoma using DOTA-conjugated, 90Y-radiolabeled, humanized anti-CD22 monoclonal antibody, epratuzumab.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(14):5215-22.
-
2005: Govindan Serengulam V; Michel Rosana B; Griffiths Gary L; Goldenberg David M; Mattes M Jules
Deferoxamine as a chelator for 67Ga in the preparation of antibody conjugates.
Nuclear medicine and biology 2005;32(5):513-9.
-
2005: Modrak David E; Karacay Habibe; Cardillo Thomas M; Newsome Guy; Goldenberg David M; Gold David V
Identification of a Mu-9 (anti-colon-specific antigen-p)-reactive peptide having homology to CA125 (MUC16).
International journal of oncology 2005;26(6):1591-6.
-
2005: Sharkey R M; Karacay H; Chang C-H; McBride W J; Horak I D; Goldenberg D M
Improved therapy of non-Hodgkin's lymphoma xenografts using radionuclides pretargeted with a new anti-CD20 bispecific antibody.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2005;19(6):1064-9.
-
2005: Qu Zhengxing; Griffiths Gary L; Wegener William A; Chang Chien-Hsing; Govindan Serengulam V; Horak Ivan D; Hansen Hans J; Goldenberg David M
Development of humanized antibodies as cancer therapeutics.
Methods (San Diego, Calif.) 2005;36(1):84-95.
-
2005: Michel Rosana B; Andrews Philip M; Rosario Adriane V; Goldenberg David M; Mattes M Jules
177Lu-antibody conjugates for single-cell kill of B-lymphoma cells in vitro and for therapy of micrometastases in vivo.
Nuclear medicine and biology 2005;32(3):269-78.
-
2005: Stein Rhona; Govindan Serengulam V; Hayes Marianne; Griffiths Gary L; Hansen Hans J; Horak Ivan D; Goldenberg David M
Advantage of a residualizing iodine radiolabel in the therapy of a colon cancer xenograft targeted with an anticarcinoembryonic antigen monoclonal antibody.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(7):2727-34.
-
2005: Sharkey Robert M; Hajjar George; Yeldell Dion; Brenner Arnold; Burton Jack; Rubin Arnold; Goldenberg David M
A phase I trial combining high-dose 90Y-labeled humanized anti-CEA monoclonal antibody with doxorubicin and peripheral blood stem cell rescue in advanced medullary thyroid cancer.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2005;46(4):620-33.
-
2005: Blumenthal Rosalyn D; Osorio Lou; Hayes Marianne K; Horak Ivan D; Hansen Hans J; Goldenberg David M
Carcinoembryonic antigen antibody inhibits lung metastasis and augments chemotherapy in a human colonic carcinoma xenograft.
Cancer immunology, immunotherapy : CII 2005;54(4):315-27.
-
2005: Mirallié E; Vuillez J P; Bardet S; Frampas E; Dupas B; Ferrer L; Faivre-Chauvet A; Murat A; Charbonnel B; Barbet J; Goldenberg D M; Chatal J F; Kraeber-Bodéré F
High frequency of bone/bone marrow involvement in advanced medullary thyroid cancer.
The Journal of clinical endocrinology and metabolism 2005;90(2):779-88.
-
2005: Michel Rosana B; Rosario Adriane V; Andrews Philip M; Goldenberg David M; Mattes M Jules
Therapy of small subcutaneous B-lymphoma xenografts with antibodies conjugated to radionuclides emitting low-energy electrons.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(2 Pt 1):777-86.
-
2005: Sharkey Robert M; Goldenberg David M
Perspectives on cancer therapy with radiolabeled monoclonal antibodies.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2005;46 Suppl 1():115S-27S.
-
2005: Govindan Serengulam V; Griffiths Gary L; Stein Rhona; Andrews Philip; Sharkey Robert M; Hansen Hans J; Horak Ivan D; Goldenberg David M
Clinical-scale radiolabeling of a humanized anticarcinoembryonic antigen monoclonal antibody, hMN-14, with residualizing 131I for use in radioimmunotherapy.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2005;46(1):153-9.
-
2004: Stein Rhona; Goldenberg David M
A humanized monoclonal antibody to carcinoembryonic antigen, labetuzumab, inhibits tumor growth and sensitizes human medullary thyroid cancer xenografts to dacarbazine chemotherapy.
Molecular cancer therapeutics 2004;3(12):1559-64.
-
2004: Stein Rhona; Qu Zhengxing; Cardillo Thomas M; Chen Susan; Rosario Adriane; Horak Ivan D; Hansen Hans J; Goldenberg David M
Antiproliferative activity of a humanized anti-CD74 monoclonal antibody, hLL1, on B-cell malignancies.
Blood 2004;104(12):3705-11.
-
2004: Modrak David E; Cardillo Thomas M; Newsome Guy A; Goldenberg David M; Gold David V
Synergistic interaction between sphingomyelin and gemcitabine potentiates ceramide-mediated apoptosis in pancreatic cancer.
Cancer research 2004;64(22):8405-10.
-
2004: Burton Jack D; Ely Scott; Reddy Praveen K; Stein Rhona; Gold David V; Cardillo Thomas M; Goldenberg David M
CD74 is expressed by multiple myeloma and is a promising target for therapy.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(19):6606-11.
-
2004: Passalaqua Anthony M; Klein Robert L; Wegener William A; Crawford Joseph A; Crow John P; Andrews David A; Goldenberg David M
Diagnosing suspected acute nonclassic appendicitis with sulesomab, a radiolabeled antigranulocyte antibody imaging agent.
Journal of pediatric surgery 2004;39(9):1338-44.
-
2004: Leonard John P; Coleman Morton; Ketas Jamie C; Chadburn Amy; Furman Richard; Schuster Michael W; Feldman Eric J; Ashe Michelle; Schuster Stephen J; Wegener William A; Hansen Hans J; Ziccardi Heather; Eschenberg Michael; Gayko Urte; Fields Scott Z; Cesano Alessandra; Goldenberg David M
Epratuzumab, a humanized anti-CD22 antibody, in aggressive non-Hodgkin's lymphoma: phase I/II clinical trial results.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(16):5327-34.
-
2004: Cardillo Thomas M; Karacay Habibe; Goldenberg David M; Yeldell Dion; Chang Chien-Hsing; Modrak David E; Sharkey Robert M; Gold David V
Improved targeting of pancreatic cancer: experimental studies of a new bispecific antibody, pretargeting enhancement system for immunoscintigraphy.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(10):3552-61.
-
2004: Stein Rhona; Qu Zhengxing; Chen Susan; Rosario Adriane; Shi Victoria; Hayes Marianne; Horak Ivan D; Hansen Hans J; Goldenberg David M
Characterization of a new humanized anti-CD20 monoclonal antibody, IMMU-106, and Its use in combination with the humanized anti-CD22 antibody, epratuzumab, for the therapy of non-Hodgkin's lymphoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(8):2868-78.
-
2004: Govindan Serengulam V; Stein Rhona; Qu Zhengxing; Chen Susan; Andrews Philip; Ma Hong; Hansen Hans J; Griffiths Gary L; Horak Ivan D; Goldenberg David M
Preclinical therapy of breast cancer with a radioiodinated humanized anti-EGP-1 monoclonal antibody: advantage of a residualizing iodine radiolabel.
Breast cancer research and treatment 2004;84(2):173-82.
-
2004: Griffiths Gary L; Chang Chien-Hsing; McBride William J; Rossi Edmund A; Sheerin Agatha; Tejada German R; Karacay Habibe; Sharkey Robert M; Horak Ivan D; Hansen Hans J; Goldenberg David M
Reagents and methods for PET using bispecific antibody pretargeting and 68Ga-radiolabeled bivalent hapten-peptide-chelate conjugates.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2004;45(1):30-9.
-
2004: Blumenthal Rosalyn D; Leone Evelyn; Goldenberg David M; Rodriguez Marisol; Modrak David
An in vitro model to optimize dose scheduling of multimodal radioimmunotherapy and chemotherapy: effects of p53 expression.
International journal of cancer. Journal international du cancer 2004;108(2):293-300.
-
2003: Griffiths Gary L; Mattes M Jules; Stein Rhona; Govindan Serengulam V; Horak Ivan D; Hansen Hans J; Goldenberg David M
Cure of SCID mice bearing human B-lymphoma xenografts by an anti-CD74 antibody-anthracycline drug conjugate.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(17):6567-71.
-
2003: Sharkey Robert M; Brenner Arnold; Burton Jack; Hajjar George; Toder Stephen P; Alavi Abass; Matthies Alexander; Tsai Donald E; Schuster Stephen J; Stadtmauer Edward A; Czuczman Myron S; Lamonica Dominick; Kraeber-Bodere Françoise; Mahe Beatrice; Chatal Jean-François; Rogatko André; Mardirrosian George; Goldenberg David M
Radioimmunotherapy of non-Hodgkin's lymphoma with 90Y-DOTA humanized anti-CD22 IgG (90Y-Epratuzumab): do tumor targeting and dosimetry predict therapeutic response?
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2003;44(12):2000-18.
-
2003: Blumenthal R D; Leone E; Goldenberg D M
Tumor-specific dose scheduling of bimodal radioimmunotherapy and chemotherapy.
Anticancer research 2003;23(6C):4613-9.
-
2003: Sharkey Robert M; Sausville Edward A; Goldenberg David M
Meeting report on the Ninth Conference on Cancer Therapy with Antibodies and Immunoconjugates.
Cancer research 2003;63(22):8069-71.
-
2003: Michel Rosana B; Rosario Adriane V; Brechbiel Martin W; Jackson Thomas J; Goldenberg David M; Mattes M Jules
Experimental therapy of disseminated B-Cell lymphoma xenografts with 213Bi-labeled anti-CD74.
Nuclear medicine and biology 2003;30(7):715-23.
-
2003: Coleman Morton; Goldenberg David M; Siegel Abby B; Ketas Jamie C; Ashe Michelle; Fiore Jennifer M; Leonard John P
Epratuzumab: targeting B-cell malignancies through CD22.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(10 Pt 2):3991S-4S.
-
2003: Kraeber-Bodéré Françoise; Faivre-Chauvet Alain; Ferrer Ludovic; Vuillez Jean-Philippe; Brard Pierre-Yves; Rousseau Caroline; Resche Isabelle; Devillers Anne; Laffont Sophie; Bardiès Manuel; Chang Ken; Sharkey Robert M; Goldenberg David M; Chatal Jean-François; Barbet Jacques
Pharmacokinetics and dosimetry studies for optimization of anti-carcinoembryonic antigen x anti-hapten bispecific antibody-mediated pretargeting of Iodine-131-labeled hapten in a phase I radioimmunotherapy trial.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(10 Pt 2):3973S-81S.
-
2003: Sharkey Robert M; Karacay Habibe; Richel Heidi; McBride William J; Rossi Edmund A; Chang Ken; Yeldell Dion; Griffiths Gary L; Hansen Hans J; Goldenberg David M
Optimizing bispecific antibody pretargeting for use in radioimmunotherapy.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(10 Pt 2):3897S-913S.
-
2003: Rossi Edmund A; Sharkey Robert M; McBride William; Karacay Habibe; Zeng Li; Hansen Hans J; Goldenberg David M; Chang Chien-Hsing
Development of new multivalent-bispecific agents for pretargeting tumor localization and therapy.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(10 Pt 2):3886S-96S.
-
2003: Siegel Abby B; Goldenberg David M; Cesano Alessandra; Coleman Morton; Leonard John P
CD22-directed monoclonal antibody therapy for lymphoma.
Seminars in oncology 2003;30(4):457-64.
-
2003: Leonard John P; Coleman Morton; Ketas Jamie C; Chadburn Amy; Ely Scott; Furman Richard R; Wegener William A; Hansen Hans J; Ziccardi Heather; Eschenberg Michael; Gayko Urte; Cesano Alessandra; Goldenberg David M
Phase I/II trial of epratuzumab (humanized anti-CD22 antibody) in indolent non-Hodgkin's lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(16):3051-9.
-
2003: Tsai Donald E; Maillard Ivan; Schuster Stephen J; Nasta Sunita D; Porter David L; Klumpp Thomas R; Goldenberg David M; Luger Selina M; Alavi Abass; Sharkey Robert M; Hartzell Kenneth B; Stadtmauer Edward A
Use of ibritumomab tiuxetan anti-CD20 radioimmunotherapy in a non-Hodgkin's lymphoma patient previously treated with a yttrium-90-labeled anti-CD22 monoclonal antibody.
Clinical lymphoma 2003;4(1):56-9.
-
2003: Taylor Alice P; Rodriguez Marisol; Adams Kelly; Goldenberg David M; Blumenthal Rosalyn D
Altered tumor vessel maturation and proliferation in placenta growth factor-producing tumors: potential relationship to post-therapy tumor angiogenesis and recurrence.
International journal of cancer. Journal international du cancer 2003;105(2):158-64.
-
2003: Goldenberg David M
Advancing role of radiolabeled antibodies in the therapy of cancer.
Cancer immunology, immunotherapy : CII 2003;52(5):281-96.
-
2003: Goldenberg David M; Chang Chien-Hsing; Sharkey Robert M; Rossi Edmund A; Karacay Habibe; McBride William; Hansen Hans J; Chatal Jean-Francois; Barbet Jacques
Radioimmunotherapy: is avidin-biotin pretargeting the preferred choice among pretargeting methods?
European journal of nuclear medicine and molecular imaging 2003;30(5):777-80.
-
2003: Reddy P K; Gold D V; Cardillo T M; Goldenberg D M; Li H; Burton J D
Interferon-gamma upregulates MUC1 expression in haematopoietic and epithelial cancer cell lines, an effect associated with MUC1 mRNA induction.
European journal of cancer (Oxford, England : 1990) 2003;39(3):397-404.
-
2003: Modrak D E; Gold D V; Goldenberg D M; Blumenthal R D
Colonic tumor CEA, CSAp and MUC-1 expression following radioimmunotherapy or chemotherapy.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2003;24(1):32-9.
-
2003: Sharkey Robert M; McBride William J; Karacay Habibe; Chang Ken; Griffiths Gary L; Hansen Hans J; Goldenberg David M
A universal pretargeting system for cancer detection and therapy using bispecific antibody.
Cancer research 2003;63(2):354-63.
-
2003: Stein Rhona; Govindan Serengulam V; Mattes M Jules; Chen Susan; Reed Linda; Newsome Guy; McBride Bill J; Griffiths Gary L; Hansen Hans J; Goldenberg David M
Improved iodine radiolabels for monoclonal antibody therapy.
Cancer research 2003;63(1):111-8.
-
2003: Siegel Jeffry A; Yeldell Dion; Goldenberg David M; Stabin Michael G; Sparks Richard B; Sharkey Robert M; Brenner Arnold; Blumenthal Rosalyn D
Red marrow radiation dose adjustment using plasma FLT3-L cytokine levels: improved correlations between hematologic toxicity and bone marrow dose for radioimmunotherapy patients.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2003;44(1):67-76.
-
2002: Blumenthal Rosalyn D; Taylor Alice P; Goldman Lisa; Brown Gloria; Goldenberg David M
Abnormal expression of the angiopoietins and Tie receptors in menorrhagic endometrium.
Fertility and sterility 2002;78(6):1294-300.
-
2002: Karacay H; Sharkey R M; McBride W J; Griffiths G L; Qu Z; Chang K; Hansen H J; Goldenberg D M
Pretargeting for cancer radioimmunotherapy with bispecific antibodies: role of the bispecific antibody's valency for the tumor target antigen.
Bioconjugate chemistry 2002;13(5):1054-70.
-
2002: Govindan Serengulam V; Griffiths Gary L; Michel Rosana B; Andrews Philip M; Goldenberg David M; Mattes M Jules
Use of galactosylated-streptavidin as a clearing agent with 111In-labeled, biotinylated antibodies to enhance tumor/non-tumor localization ratios.
Cancer biotherapy & radiopharmaceuticals 2002;17(3):307-16.
-
2002: Chang Chien-Hsing; Sharkey Robert M; Rossi Edmund A; Karacay Habibe; McBride William; Hansen Hans J; Chatal Jean-François; Barbet Jacques; Goldenberg David M
Molecular advances in pretargeting radioimunotherapy with bispecific antibodies.
Molecular cancer therapeutics 2002;1(7):553-63.
-
2002: Hajjar George; Sharkey Robert M; Burton Jack; Zhang Chu-Hui; Yeldell Dion; Matthies Alexander; Alavi Abass; Losman Michele J; Brenner Arnold; Goldenberg David M
Phase I radioimmunotherapy trial with iodine-131--labeled humanized MN-14 anti-carcinoembryonic antigen monoclonal antibody in patients with metastatic gastrointestinal and colorectal cancer.
Clinical colorectal cancer 2002;2(1):31-42.
-
2002: Blumenthal Rosalyn D; Reising Albert; Leon Evelyn; Goldenberg David M
Modulation of marrow proliferation and chemosensitivity by tumor-produced cytokines from syngeneic pancreatic tumor lines.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(5):1301-9.
-
2002: Goldenberg David M
Targeted therapy of cancer with radiolabeled antibodies.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2002;43(5):693-713.
-
2002: Taylor Alice P; Osorio Louis; Craig Russell; Raleigh James A; Ying Zhiliang; Goldenberg David M; Blumenthal Rosalyn D
Tumor-specific regulation of angiogenic growth factors and their receptors during recovery from cytotoxic therapy.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(4):1213-22.
-
2002: Waskewich Chris; Blumenthal Rosalyn D; Li Honglan; Stein Rhona; Goldenberg David M; Burton Jack
Celecoxib exhibits the greatest potency amongst cyclooxygenase (COX) inhibitors for growth inhibition of COX-2-negative hematopoietic and epithelial cell lines.
Cancer research 2002;62(7):2029-33.
-
2002: Behr Thomas M; Liersch Torsten; Greiner-Bechert Lutz; Griesinger Frank; Béhé Martin; Markus Peter M; Gratz Stefan; Angerstein Christa; Brittinger Gerhard; Becker Heinz; Goldenberg David M; Becker Wolfgang
Radioimmunotherapy of small-volume disease of metastatic colorectal cancer.
Cancer 2002;94(4 Suppl):1373-81.
-
2002: Goldenberg David M
Eighth Conference on Radioimmunodetection and Radioimmunotherapy of Cancer. Introduction.
Cancer 2002;94(4 Suppl):1193-5.
-
2002: Modrak David E; Rodriguez Marisol D; Goldenberg David M; Lew Walter; Blumenthal Rosalyn D
Sphingomyelin enhances chemotherapy efficacy and increases apoptosis in human colonic tumor xenografts.
International journal of oncology 2002;20(2):379-84.
-
2002: Stein Rhona; Chen Susan; Reed Linda; Richel Heidi; Goldenberg David M
Combining radioimmunotherapy and chemotherapy for treatment of medullary thyroid carcinoma: effectiveness of dacarbazine.
Cancer 2002;94(1):51-61.
-
2001: Blumenthal R D; Taylor A; Osorio L; Ochakovskaya R; Raleigh J A; Papadopoulou M; Bloomer W D; Goldenberg D M
Optimizing the use of combined radioimmunotherapy and hypoxic cytotoxin therapy as a function of tumor hypoxia.
International journal of cancer. Journal international du cancer 2001;94(4):564-71.
-
2001: Blumenthal R D; Waskewich C; Goldenberg D M; Lew W; Flefleh C; Burton J
Chronotherapy and chronotoxicity of the cyclooxygenase-2 inhibitor, celecoxib, in athymic mice bearing human breast cancer xenografts.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(10):3178-85.
-
2001: Goldenberg D M
The role of radiolabeled antibodies in the treatment of non-Hodgkin's lymphoma: the coming of age of radioimmunotherapy.
Critical reviews in oncology/hematology 2001;39(1-2):195-201.
-
2001: Stein R; Govindan S V; Chen S; Reed L; Spiegelman H; Griffiths G L; Hansen H J; Goldenberg D M
Successful therapy of a human lung cancer xenograft using MAb RS7 labeled with residualizing radioiodine.
Critical reviews in oncology/hematology 2001;39(1-2):173-80.
-
2001: Gold D V; Cardillo T; Goldenberg D M; Sharkey R M
Localization of pancreatic cancer with radiolabeled monoclonal antibody PAM4.
Critical reviews in oncology/hematology 2001;39(1-2):147-54.
-
2001: Ochakovskaya R; Osorio L; Goldenberg D M; Mattes M J
Therapy of disseminated B-cell lymphoma xenografts in severe combined immunodeficient mice with an anti-CD74 antibody conjugated with (111)indium, (67)gallium, or (90)yttrium.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(6):1505-10.
-
2001: Stein R; Govindan S V; Chen S; Reed L; Richel H; Griffiths G L; Hansen H J; Goldenberg D M
Radioimmunotherapy of a human lung cancer xenograft with monoclonal antibody RS7: evaluation of (177)Lu and comparison of its efficacy with that of (90)Y and residualizing (131)I.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2001;42(6):967-74.
-
2001: Ong G L; Elsamra S E; Goldenberg D M; Mattes M J
Single-cell cytotoxicity with radiolabeled antibodies.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(1):192-201.
-
2000: Behr T M; Blumenthal R D; Memtsoudis S; Sharkey R M; Gratz S; Becker W; Goldenberg D M
Cure of metastatic human colonic cancer in mice with radiolabeled monoclonal antibody fragments.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(12):4900-7.
-
2000: Govindan S V; Goldenberg D M; Elsamra S E; Griffiths G L; Ong G L; Brechbiel M W; Burton J; Sgouros G; Mattes M J
Radionuclides linked to a CD74 antibody as therapeutic agents for B-cell lymphoma: comparison of Auger electron emitters with beta-particle emitters.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2000;41(12):2089-97.
-
2000: Karacay H; McBride W J; Griffiths G L; Sharkey R M; Barbet J; Hansen H J; Goldenberg D M
Experimental pretargeting studies of cancer with a humanized anti-CEA x murine anti-[In-DTPA] bispecific antibody construct and a (99m)Tc-/(188)Re-labeled peptide.
Bioconjugate chemistry 2000;11(6):842-54.
-
2000: Blumenthal R D; Osorio L; Ochakovskaya R; Ying Z; Goldenberg D M
Regulation of tumour drug delivery by blood flow chronobiology.
European journal of cancer (Oxford, England : 1990) 2000;36(14):1876-84.
-
2000: Shih L; Ong G L; Burton J; Mishina D; Goldenberg D M; Mattes M J
Localization of an antibody to CD74 (MHC class II invariant chain) to human B cell lymphoma xenografts in nude mice.
Cancer immunology, immunotherapy : CII 2000;49(4-5):208-16.
-
2000: Goldenberg D M; Abdel-Nabi H; Sullivan C L; Serafini A; Seldin D; Barron B; Lamki L; Line B; Wegener W A
Carcinoembryonic antigen immunoscintigraphy complements mammography in the diagnosis of breast carcinoma.
Cancer 2000;89(1):104-15.
-
2000: Tsai D E; Schuster S J; Matthies A; Moore H C; Alavi A; Juweid M E; Goldenberg D M; Stadtmauer E A
Progressive intermediate-grade non-Hodgkin's lymphoma after high-dose therapy and autologous peripheral stem-cell transplantation: changing the natural history with monoclonal antibody therapy.
Clinical lymphoma 2000;1(1):62-6.
-
2000: Wegener W A; Petrelli N; Serafini A; Goldenberg D M
Safety and efficacy of arcitumomab imaging in colorectal cancer after repeated administration.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2000;41(6):1016-20.
-
2000: Blumenthal R D; Samoszuk M; Taylor A P; Brown G; Alisauskas R; Goldenberg D M
Degranulating eosinophils in human endometriosis.
The American journal of pathology 2000;156(5):1581-8.
-
2000: Blumenthal R D; Lew W; Reising A; Soyne D; Osorio L; Ying Z; Goldenberg D M
Anti-oxidant vitamins reduce normal tissue toxicity induced by radio-immunotherapy.
International journal of cancer. Journal international du cancer 2000;86(2):276-80.
-
2000: Modrak D E; Lew W; Goldenberg D M; Blumenthal R
Sphingomyelin potentiates chemotherapy of human cancer xenografts.
Biochemical and biophysical research communications 2000;268(2):603-6.
-
2000: Juweid M E; Hajjar G; Stein R; Sharkey R M; Herskovic T; Swayne L C; Suleiman S; Pereira M; Rubin A D; Goldenberg D M
Initial experience with high-dose radioimmunotherapy of metastatic medullary thyroid cancer using 131I-MN-14 F(ab)2 anti-carcinoembryonic antigen MAb and AHSCR.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2000;41(1):93-103.
-
2000: Blumenthal R D; Lew W; Juweid M; Alisauskas R; Ying Z; Goldenberg D M
Plasma FLT3-L levels predict bone marrow recovery from myelosuppressive therapy.
Cancer 2000;88(2):333-43.
-
1999: Juweid M E; Blumenthal R D; Lew W; Hajjar G; Rubin A D; Goldenberg D M
Importance of timing of radioimmunotherapy after granulocyte colony-stimulating factor administration for peripheral blood stem cell harvest.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(10 Suppl):3337s-3342s.
-
1999: Behr T M; Wörmann B; Gramatzki M; Riggert J; Gratz S; Béhé M; Griesinger F; Sharkey R M; Kolb H J; Hiddemann W; Goldenberg D M; Becker W
Low- versus high-dose radioimmunotherapy with humanized anti-CD22 or chimeric anti-CD20 antibodies in a broad spectrum of B cell-associated malignancies.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(10 Suppl):3304s-3314s.
-
1999: Juweid M E; Stadtmauer E; Hajjar G; Sharkey R M; Suleiman S; Luger S; Swayne L C; Alavi A; Goldenberg D M
Pharmacokinetics, dosimetry, and initial therapeutic results with 131I- and (111)In-/90Y-labeled humanized LL2 anti-CD22 monoclonal antibody in patients with relapsed, refractory non-Hodgkin's lymphoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(10 Suppl):3292s-3303s.
-
1999: Behr T M; Salib A L; Liersch T; Béhé M; Angerstein C; Blumenthal R D; Fayyazi A; Sharkey R M; Ringe B; Becker H; Wörmann B; Hiddemann W; Goldenberg D M; Becker W
Radioimmunotherapy of small volume disease of colorectal cancer metastatic to the liver: preclinical evaluation in comparison to standard chemotherapy and initial results of a phase I clinical study.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(10 Suppl):3232s-3242s.
-
1999: Stein R; Juweid M; Zhang C H; Goldenberg D M
Assessment of combined radioimmunotherapy and chemotherapy for treatment of medullary thyroid cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(10 Suppl):3199s-3206s.
-
1999: Leung S O; Qu Z; Hansen H J; Shih L B; Wang J; Losman M J; Goldenberg D M; Sharkey R M
The effects of domain deletion, glycosylation, and long IgG3 hinge on the biodistribution and serum stability properties of a humanized IgG1 immunoglobulin, hLL2, and its fragments.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(10 Suppl):3106s-3117s.
-
1999: Losman M J; Qu Z; Krishnan I S; Wang J; Hansen H J; Goldenberg D M; Leung S O
Generation and monitoring of cell lines producing humanized antibodies.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(10 Suppl):3101s-3105s.
-
1999: Qu Z; Losman M J; Eliassen K C; Hansen H J; Goldenberg D M; Leung S O
Humanization of Immu31, an alpha-fetoprotein-specific antibody.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(10 Suppl):3095s-3100s.
-
1999: Stein R; Govindan S V; Mattes M J; Shih L B; Griffiths G L; Hansen H J; Goldenberg D M
Targeting human cancer xenografts with monoclonal antibodies labeled using radioiodinated, diethylenetriaminepentaacetic acid-appended peptides.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(10 Suppl):3079s-3087s.
-
1999: Burton J; Mishina D; Cardillo T; Lew K; Rubin A; Goldenberg D M; Gold D V
Epithelial mucin-1 (MUC1) expression and MA5 anti-MUC1 monoclonal antibody targeting in multiple myeloma.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(10 Suppl):3065s-3072s.
-
1999: Behr T M; Sgouros G; Stabin M G; Béhé M; Angerstein C; Blumenthal R D; Apostolidis C; Molinet R; Sharkey R M; Koch L; Goldenberg D M; Becker W
Studies on the red marrow dosimetry in radioimmunotherapy: an experimental investigation of factors influencing the radiation-induced myelotoxicity in therapy with beta-, Auger/conversion electron-, or alpha-emitters.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(10 Suppl):3031s-3043s.
-
1999: Griffiths G L; Goldenberg D M; Roesch F; Hansen H J
Radiolabeling of an anti-carcinoembryonic antigen antibody Fab' fragment (CEA-Scan) with the positron-emitting radionuclide Tc-94m.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(10 Suppl):3001s-3003s.
-
1999: Goldenberg D M
Introduction to the Seventh Conference on Radioimmunodetection and Radioimmunodetection and Radioimmunotherapy of Cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(10 Suppl):2991s.
-
1999: Ong G L; Goldenberg D M; Hansen H J; Mattes M J
Cell surface expression and metabolism of major histocompatibility complex class II invariant chain (CD74) by diverse cell lines.
Immunology 1999;98(2):296-302.
-
1999: Juweid M E; Zhang C H; Blumenthal R D; Hajjar G; Sharkey R M; Goldenberg D M
Prediction of hematologic toxicity after radioimmunotherapy with (131)I-labeled anticarcinoembryonic antigen monoclonal antibodies.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1999;40(10):1609-16.
-
1999: Krishnan I S; Hansen H J; Gold D V; Goldenberg D M; Leung S O
Co-secretion of two distinct kappa light chains by the mu-9 hybridoma.
Hybridoma 1999;18(4):325-33.
-
1999: Patel S; Stein R; Ong G L; Goldenberg D M; Mattes M J
Enhancement of tumor-to-nontumor localization ratios by hepatocyte-directed blood clearance of antibodies labeled with certain residualizing radiolabels.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1999;40(8):1392-401.
-
1999: Behr T M; Béhé M; Stabin M G; Wehrmann E; Apostolidis C; Molinet R; Strutz F; Fayyazi A; Wieland E; Gratz S; Koch L; Goldenberg D M; Becker W
High-linear energy transfer (LET) alpha versus low-LET beta emitters in radioimmunotherapy of solid tumors: therapeutic efficacy and dose-limiting toxicity of 213Bi- versus 90Y-labeled CO17-1A Fab' fragments in a human colonic cancer model.
Cancer research 1999;59(11):2635-43.
-
1999: Blumenthal R D; Reising A; Lew W; Dunn R; Ying Z; Goldenberg D M
Chronotolerance of experimental radioimmunotherapy: clearance, toxicity, and maximal tolerated dose of 131I-anti-carcinoembryonic antigen (CEA) IgG as a function of time of day of dosing in a murine model.
European journal of cancer (Oxford, England : 1990) 1999;35(5):815-24.
-
1999: Juweid M E; Hajjar G; Swayne L C; Sharkey R M; Suleiman S; Herskovic T; Pereira M; Rubin A D; Goldenberg D M
Phase I/II trial of (131)I-MN-14F(ab)2 anti-carcinoembryonic antigen monoclonal antibody in the treatment of patients with metastatic medullary thyroid carcinoma.
Cancer 1999;85(8):1828-42.
-
1999: Govindan S V; Mattes M J; Stein R; McBride B J; Karacay H; Goldenberg D M; Hansen H J; Griffiths G L
Labeling of monoclonal antibodies with diethylenetriaminepentaacetic acid-appended radioiodinated peptides containing D-amino acids.
Bioconjugate chemistry 1999;10(2):231-40.
-
1999: Barron B; Hanna C; Passalaqua A M; Lamki L; Wegener W A; Goldenberg D M
Rapid diagnostic imaging of acute, nonclassic appendicitis by leukoscintigraphy with sulesomab, a technetium 99m-labeled antigranulocyte antibody Fab' fragment. LeukoScan Appendicitis Clinical Trial Group.
Surgery 1999;125(3):288-96.
-
1999: Stein R; Juweid M; Mattes M J; Goldenberg D M
Carcinoembryonic antigen as a target for radioimmunotherapy of human medullary thyroid carcinoma: antibody processing, targeting, and experimental therapy with 131I and 90Y labeled MAbs.
Cancer biotherapy & radiopharmaceuticals 1999;14(1):37-47.
-
1999: Goldenberg D M; Nabi H A
Breast cancer imaging with radiolabeled antibodies.
Seminars in nuclear medicine 1999;29(1):41-8.
-
1998: Govindan S V; Shih L B; Goldenberg D M; Sharkey R M; Karacay H; Donnelly J E; Losman M J; Hansen H J; Griffiths G L
90Yttrium-labeled complementarity-determining-region-grafted monoclonal antibodies for radioimmunotherapy: radiolabeling and animal biodistribution studies.
Bioconjugate chemistry 1998;9(6):773-82.
-
1998: Blumenthal R D; Alisauskas R; Lew W; Sharkey R M; Goldenberg D M
Myelosuppressive changes from single or repeated doses of radioantibody therapy: effect of bone marrow transplantation, cytokines, and hematopoietic suppression.
Experimental hematology 1998;26(9):859-68.
-
1998: Behr T M; Memtsoudis S; Sharkey R M; Blumenthal R D; Dunn R M; Gratz S; Wieland E; Nebendahl K; Schmidberger H; Goldenberg D M; Becker W
Experimental studies on the role of antibody fragments in cancer radio-immunotherapy: Influence of radiation dose and dose rate on toxicity and anti-tumor efficacy.
International journal of cancer. Journal international du cancer 1998;77(5):787-95.
-
1998: Behr T M; Sgouros G; Vougiokas V; Memtsoudis S; Gratz S; Schmidberger H; Blumenthal R D; Goldenberg D M; Becker W
Therapeutic efficacy and dose-limiting toxicity of Auger-electron vs. beta emitters in radioimmunotherapy with internalizing antibodies: evaluation of 125I- vs. 131I-labeled CO17-1A in a human colorectal cancer model.
International journal of cancer. Journal international du cancer 1998;76(5):738-48.
-
1998: Qu Z; Sharkey R M; Hansen H J; Shih L B; Govindan S V; Shen J; Goldenberg D M; Leung S O
Carbohydrates engineered at antibody constant domains can be used for site-specific conjugation of drugs and chelates.
Journal of immunological methods 1998;213(2):131-44.
-
1998: Reddy N; Ong G L; Behr T M; Sharkey R M; Goldenberg D M; Mattes M J
Rapid blood clearance of mouse IgG2a and human IgG1 in many nude and nu/+ mouse strains is due to low IgG2a serum concentrations.
Cancer immunology, immunotherapy : CII 1998;46(1):25-33.
-
1998: Behr T M; Goldenberg D M; Becker W
Reducing the renal uptake of radiolabeled antibody fragments and peptides for diagnosis and therapy: present status, future prospects and limitations.
European journal of nuclear medicine 1998;25(2):201-12.
-
1998: Juweid M; Sharkey R M; Swayne L C; Griffiths G L; Dunn R; Goldenberg D M
Pharmacokinetics, dosimetry and toxicity of rhenium-188-labeled anti-carcinoembryonic antigen monoclonal antibody, MN-14, in gastrointestinal cancer.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1998;39(1):34-42.
-
1997: Juweid M; Swayne L C; Sharkey R M; Dunn R; Rubin A D; Herskovic T; Goldenberg D M
Prospects of radioimmunotherapy in epithelial ovarian cancer: results with iodine-131-labeled murine and humanized MN-14 anti-carcinoembryonic antigen monoclonal antibodies.
Gynecologic oncology 1997;67(3):259-71.
-
1997: Juweid M; Sharkey R M; Swayne L C; Goldenberg D M
Improved selection of patients for reoperation for medullary thyroid cancer by imaging with radiolabeled anticarcinoembryonic antigen antibodies.
Surgery 1997;122(6):1156-65.
-
1997: Juweid M E; Zhang C H; Blumenthal R D; Sharkey R M; Dunn R; Dunlop D; Goldenberg D M
Factors influencing hematologic toxicity of radioimmunotherapy with 131I-labeled anti-carcinoembryonic antigen antibodies.
Cancer 1997;80(12 Suppl):2749-53.
-
1997: Krishnan I S; Hansen H J; Losman M J; Goldenberg D M; Leung S O
Chimerization of Mu-9: a colon-specific antigen-p antibody reactive with gastrointestinal carcinomas.
Cancer 1997;80(12 Suppl):2667-74.
-
1997: Losman M J; Hansen H J; Dworak H; Krishnan I S; Qu Z; Shih L B; Zeng L; Goldenberg D M; Leung S O
Generation of a high-producing clone of a humanized anti-B-cell lymphoma monoclonal antibody (hLL2).
Cancer 1997;80(12 Suppl):2660-6.
-
1997: Dunn R M; Juweid M; Sharkey R M; Behr T M; Goldenberg D M
Can occult metastases be treated by radioimmunotherapy?
Cancer 1997;80(12 Suppl):2656-9.
-
1997: Stein R; Chen S; Haim S; Goldenberg D M
Advantage of yttrium-90-labeled over iodine-131-labeled monoclonal antibodies in the treatment of a human lung carcinoma xenograft.
Cancer 1997;80(12 Suppl):2636-41.
-
1997: Blumenthal R D; Alisauskas R; Juweid M; Sharkey R M; Goldenberg D M
Defining the optimal spacing between repeat radioantibody doses in experimental models: is there an accurate measurement for hematopoietic recovery?
Cancer 1997;80(12 Suppl):2624-35.
-
1997: Behr T M; Sharkey R M; Sgouros G; Blumenthal R D; Dunn R M; Kolbert K; Griffiths G L; Siegel J A; Becker W S; Goldenberg D M
Overcoming the nephrotoxicity of radiometal-labeled immunoconjugates: improved cancer therapy administered to a nude mouse model in relation to the internal radiation dosimetry.
Cancer 1997;80(12 Suppl):2591-610.
-
1997: Qu Z; Sharkey R M; Hansen H J; Goldenberg D M; Leung S
Structure determination of N-linked oligosaccharides engineered at the CH1 domain of humanized LL2.
Glycobiology 1997;7(6):803-9.
-
1997: Stein R; Goldenberg D M; Ong G L; Thorpe S R; Mattes M J
Manipulation of blood clearance to optimize delivery of residualizing label-antibody conjugates to tumor cells in vivo.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1997;38(9):1392-400.
-
1997: Sharkey R M; Karacay H; Griffiths G L; Behr T M; Blumenthal R D; Mattes M J; Hansen H J; Goldenberg D M
Development of a streptavidin-anti-carcinoembryonic antigen antibody, radiolabeled biotin pretargeting method for radioimmunotherapy of colorectal cancer. Studies in a human colon cancer xenograft model.
Bioconjugate chemistry 1997;8(4):595-604.
-
1997: Karacay H; Sharkey R M; Govindan S V; McBride W J; Goldenberg D M; Hansen H J; Griffiths G L
Development of a streptavidin-anti-carcinoembryonic antigen antibody, radiolabeled biotin pretargeting method for radioimmunotherapy of colorectal cancer. Reagent development.
Bioconjugate chemistry 1997;8(4):585-94.
-
1997: Sharkey R M; Blumenthal R D; Behr T M; Wong G Y; Haywood L; Forman D; Griffiths G L; Goldenberg D M
Selection of radioimmunoconjugates for the therapy of well-established or micrometastatic colon carcinoma.
International journal of cancer. Journal international du cancer 1997;72(3):477-85.
-
1997: Blumenthal R D; Sharkey R M; Haywood L; Behr T; Goldenberg D M
Application of cytokine intervention for improved radio-antibody dose delivery.
International journal of cancer. Journal international du cancer 1997;72(1):166-73.
-
1997: Behr T M; Sharkey R M; Juweid M E; Dunn R M; Vagg R C; Ying Z; Zhang C H; Swayne L C; Vardi Y; Siegel J A; Goldenberg D M
Phase I/II clinical radioimmunotherapy with an iodine-131-labeled anti-carcinoembryonic antigen murine monoclonal antibody IgG.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1997;38(6):858-70.
-
1997: Sharkey R M; Behr T M; Mattes M J; Stein R; Griffiths G L; Shih L B; Hansen H J; Blumenthal R D; Dunn R M; Juweid M E; Goldenberg D M
Advantage of residualizing radiolabels for an internalizing antibody against the B-cell lymphoma antigen, CD22.
Cancer immunology, immunotherapy : CII 1997;44(3):179-88.
-
1997: Mattes M J; Shih L B; Govindan S V; Sharkey R M; Ong G L; Xuan H; Goldenberg D M
The advantage of residualizing radiolabels for targeting B-cell lymphomas with a radiolabeled anti-CD22 monoclonal antibody.
International journal of cancer. Journal international du cancer 1997;71(3):429-35.
-
1997: Behr T M; Goldenberg D M; Scheele J R; Wolf F G; Becker W
[Clinical relevance of immunoscintigraphy with 99mTc-labelled anti-CEA antigen-binding fragments in the follow-up of patients with colorectal carcinoma. Assessment of surgical resectability with a combination of conventional imaging methods]
Deutsche medizinische Wochenschrift (1946) 1997;122(15):463-70.
-
1997: Goldenberg D M; Juweid M; Dunn R M; Sharkey R M
Cancer imaging with radiolabeled antibodies: new advances with technetium-99m-labeled monoclonal antibody Fab' fragments, especially CEA-Scan and prospects for therapy.
Journal of nuclear medicine technology 1997;25(1):18-23; quiz 34.
-
1997: Behr T M; Sharkey R M; Juweid M E; Dunn R M; Ying Z; Zhang C H; Siegel J A; Goldenberg D M
Variables influencing tumor dosimetry in radioimmunotherapy of CEA-expressing cancers with anti-CEA and antimucin monoclonal antibodies.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1997;38(3):409-18.
-
1997: Stein R; Goldenberg D M; Thorpe S R; Mattes M J
Advantage of a residualizing iodine radiolabel for radioimmunotherapy of xenografts of human non-small-cell carcinoma of the lung.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1997;38(3):391-5.
-
1997: Behr T M; Goldenberg D M; Becker W S
Radioimmunotherapy of solid tumors: a review "of mice and men".
Hybridoma 1997;16(1):101-7.
-
1997: Juweid M; Dunn R M; Sharkey R M; Rubin A D; Hansen H J; Goldenberg D M
99Tcm-LL1: a potential new bone marrow imaging agent.
Nuclear medicine communications 1997;18(2):142-8.
-
1997: Juweid M; Sharkey R M; Alavi A; Swayne L C; Herskovic T; Hanley D; Rubin A D; Pereira M; Goldenberg D M
Regression of advanced refractory ovarian cancer treated with iodine-131-labeled anti-CEA monoclonal antibody.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1997;38(2):257-60.
-
1997: Alisauskas R M; Goldenberg D M; Sharkey R M; Blumenthal R D
Reduction in the duration of myelotoxicity associated with radioimmunotherapy with infusions of the hemoregulatory peptide, HP5b in mice.
International journal of cancer. Journal international du cancer 1997;70(3):323-9.
-
1997: Blumenthal R D; Sharkey R M; Kashi R; Sides K; Stein R; Goldenberg D M
Changes in tumor vascular permeability in response to experimental radioimmunotherapy: a comparative study of 11 xenografts.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 1997;18(6):367-77.
-
1997: Goldenberg D M; Wegener W
Studies of breast cancer imaging with radiolabeled antibodies to carcinoembryonic antigen. Immunomedics Breast Cancer Study Group.
Acta medica Austriaca 1997;24(2):55-9.
-
1996: Hansen H J; Ong G L; Diril H; Valdez A; Roche P A; Griffiths G L; Goldenberg D M; Mattes M J
Internalization and catabolism of radiolabelled antibodies to the MHC class-II invariant chain by B-cell lymphomas.
The Biochemical journal 1996;320 ( Pt 1)():293-300.
-
1996: Behr T M; Juweid M E; Sharkey R M; Dunn R M; Ying Z; Becker W S; Siegel J A; Goldenberg D M
Thyroid radiation doses during radioimmunotherapy of CEA-expressing tumours with 131I-labelled monoclonal antibodies.
Nuclear medicine communications 1996;17(9):767-80.
-
1996: Juweid M E; Sharkey R M; Behr T; Swayne L C; Dunn R; Siegel J; Goldenberg D M
Radioimmunotherapy of patients with small-volume tumors using iodine-131-labeled anti-CEA monoclonal antibody NP-4 F(ab')2.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1996;37(9):1504-10.
-
1996: Becker W; Palestro C J; Winship J; Feld T; Pinsky C M; Wolf F; Goldenberg D M
Rapid imaging of infections with a monoclonal antibody fragment (LeukoScan).
Clinical orthopaedics and related research 1996;(329):263-72.
-
1996: Blumenthal R D; Stein R; Sharkey R M; Goldenberg D M; Ong G L; Klein K M; Mattes M J
Antibody penetration of tumor GS-7 xenografts in nude mice: a model for mucinous adenocarcinoma of the colon.
Cancer research 1996;56(15):3508-15.
-
1996: Juweid M; Sharkey R M; Behr T M; Swayne L C; Dunn R; Ying Z; Siegel J A; Hansen H J; Goldenberg D M
Clinical evaluation of tumor targeting with the anticarcinoembryonic antigen murine monoclonal antibody fragment, MN-14 F(ab)2.
Cancer 1996;78(1):157-68.
-
1996: Juweid M; Sharkey R M; Behr T; Swayne L C; Herskovic T; Pereira M; Rubin A D; Hanley D; Dunn R; Siegel J; Goldenberg D M
Radioimmunotherapy of medullary thyroid cancer with iodine-131-labeled anti-CEA antibodies.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1996;37(6):905-11.
-
1996: Behr T M; Becker W S; Sharkey R M; Juweid M E; Dunn R M; Bair H J; Wolf F G; Goldenberg D M
Reduction of renal uptake of monoclonal antibody fragments by amino acid infusion.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1996;37(5):829-33.
-
1996: Govindan S V; Goldenberg D M; Grebenau R C; Hansen H J; Griffiths G L
Thiolations, 99mTc labelings, and animal in vivo biodistributions of divalent monoclonal antibody fragments.
Bioconjugate chemistry 1996;7(3):290-7.
-
1996: Juweid M; Sharkey R M; Behr T; Swayne L C; Rubin A D; Herskovic T; Hanley D; Markowitz A; Dunn R; Siegel J; Kamal T; Goldenberg D M
Improved detection of medullary thyroid cancer with radiolabeled antibodies to carcinoembryonic antigen.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(4):1209-17.
-
1996: Behr T M; Sharkey R M; Juweid M I; Dunn R M; Ying Z; Zhang C H; Siegel J A; Gold D V; Goldenberg D M
Factors influencing the pharmacokinetics, dosimetry, and diagnostic accuracy of radioimmunodetection and radioimmunotherapy of carcinoembryonic antigen-expressing tumors.
Cancer research 1996;56(8):1805-16.
-
1995: Leung S O; Goldenberg D M; Dion A S; Pellegrini M C; Shevitz J; Shih L B; Hansen H J
Construction and characterization of a humanized, internalizing, B-cell (CD22)-specific, leukemia/lymphoma antibody, LL2.
Molecular immunology 1995;32(17-18):1413-27.
-
1995: Kinne R W; Becker W; Koscheck T; Kuhlmann J; Sharkey R M; Behr T; Palombo-Kinne E; Goldenberg D M; Wolf F; Emmrich F
Rat adjuvant arthritis: imaging with technetium-99m-anti-CD4 Fab' fragments.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1995;36(12):2268-75.
-
1995: Losman M J; Leung S O; Shih L B; Shevitz J; Shukla R; Haraga L; Goldenberg D M; Hansen H J
Development and evaluation of the specificity of a rat monoclonal anti-idiotype antibody, WN, to an anti-B-cell lymphoma monoclonal antibody, LL2.
Cancer research 1995;55(23 Suppl):5978s-5982s.
-
1995: Leung S O; Karacay H; Losman M J; Griffiths G L; Goldenberg D M; Hansen H J
Bacterial expression of a kemptide fusion protein facilitates 32P labeling of a humanized, anti-carcinoembryonic antigen (hMN-14) antibody fragment.
Cancer research 1995;55(23 Suppl):5968s-5972s.
-
1995: Juweid M; Sharkey R M; Behr T; Swayne L C; Rubin A D; Hanley D; Herskovic T; Markowitz A; Siegel J; Goldenberg D M
Targeting and initial radioimmunotherapy of medullary thyroid carcinoma with 131I-labeled monoclonal antibodies to carcinoembryonic antigen.
Cancer research 1995;55(23 Suppl):5946s-5951s.
-
1995: Shih L B; Xuan H; Aninipot R; Stein R; Goldenberg D M
In vitro and in vivo reactivity of an internalizing antibody, RS7, with human breast cancer.
Cancer research 1995;55(23 Suppl):5857s-5863s.
-
1995: Juweid M; Sharkey R M; Siegel J A; Behr T; Goldenberg D M
Estimates of red marrow dose by sacral scintigraphy in radioimmunotherapy patients having non-Hodgkin's lymphoma and diffuse bone marrow uptake.
Cancer research 1995;55(23 Suppl):5827s-5831s.
-
1995: Behr T; Becker W; Hannappel E; Goldenberg D M; Wolf F
Targeting of liver metastases of colorectal cancer with IgG, F(ab')2, and Fab' anti-carcinoembryonic antigen antibodies labeled with 99mTc: the role of metabolism and kinetics.
Cancer research 1995;55(23 Suppl):5777s-5785s.
-
1995: Becker W S; Behr T M; Cumme F; Rössler W; Wendler J; Kern P M; Gramatzki M; Kalden J R; Goldenberg D M; Wolf F G
67Ga citrate versus 99mTc-labeled LL2-Fab' (anti-CD22) fragments in the staging of B-cell non-Hodgkin's lymphoma.
Cancer research 1995;55(23 Suppl):5771s-5773s.
-
1995: Govindan S V; Goldenberg D M; Griffiths G L; Leung S O; Losman M J; Hansen H J
Site-specific modifications of light chain glycosylated antilymphoma (LL2) and anti-carcinoembryonic antigen (hImmu-14-N) antibody divalent f1agments.
Cancer research 1995;55(23 Suppl):5721s-5725s.
-
1995: Blumenthal R D; Sharkey R M; Forman D; Wong G; Hess J; Goldenberg D M
Improved experimental cancer therapy by radioantibody dose intensification as a result of syngeneic bone marrow transplantation.
Experimental hematology 1995;23(10):1088-97.
-
1995: Behr T M; Sharkey R M; Juweid M E; Blumenthal R D; Dunn R M; Griffiths G L; Bair H J; Wolf F G; Becker W S; Goldenberg D M
Reduction of the renal uptake of radiolabeled monoclonal antibody fragments by cationic amino acids and their derivatives.
Cancer research 1995;55(17):3825-34.
-
1995: Basu A; Goldenberg D M; Stein R
The epithelial/carcinoma antigen EGP-1, recognized by monoclonal antibody RS7-3G11, is phosphorylated on serine 303.
International journal of cancer. Journal international du cancer 1995;62(4):472-9.
-
1995: Stein R; Goldenberg D M; Thorpe S R; Basu A; Mattes M J
Effects of radiolabeling monoclonal antibodies with a residualizing iodine radiolabel on the accretion of radioisotope in tumors.
Cancer research 1995;55(14):3132-9.
-
1995: Leung S; Losman M J; Govindan S V; Griffiths G L; Goldenberg D M; Hansen H J
Engineering a unique glycosylation site for site-specific conjugation of haptens to antibody fragments.
Journal of immunology (Baltimore, Md. : 1950) 1995;154(11):5919-26.
-
1995: Goldenberg D M; Larson S M; Reisfeld R A; Schlom J
Targeting cancer with radiolabeled antibodies.
Immunology today 1995;16(6):261-4.
-
1995: Blumenthal R D; Kashi R; Sharkey R M; Goldenberg D M
Quantitative and qualitative effects of experimental radioimmunotherapy on tumor vascular permeability.
International journal of cancer. Journal international du cancer 1995;61(4):557-66.
-
1995: Leung S O; Dion A S; Pellegrini M C; Losman M J; Grebenau R C; Goldenberg D M; Hansen H J
Effect of VK framework-1 glycosylation on the binding affinity of lymphoma-specific murine and chimeric LL2 antibodies and its potential use as a novel conjugation site.
International journal of cancer. Journal international du cancer 1995;60(4):534-8.
-
1994: Leung S O; Shevitz J; Pellegrini M C; Dion A S; Shih L B; Goldenberg D M; Hansen H J
Chimerization of LL2, a rapidly internalizing antibody specific for B cell lymphoma.
Hybridoma 1994;13(6):469-76.
-
1994: Becker W; Bair J; Behr T; Repp R; Streckenbach H; Beck H; Gramatzki M; Winship M J; Goldenberg D M; Wolf F
Detection of soft-tissue infections and osteomyelitis using a technetium-99m-labeled anti-granulocyte monoclonal antibody fragment.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1994;35(9):1436-43.
-
1994: Goldenberg D M; Sharkey R M; Udem S; Vagg R; Levine G M; Conte P; Swayne L C; Hansen H J; Cunniff D; Anton J
Immunoscintigraphy of Pneumocystis carinii pneumonia in AIDS patients.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1994;35(6):1028-34.
-
1994: Griffiths G L; Goldenberg D M; Jones A L; Hansen H J
Preparation of a pure 99mTc-F(ab')2 radioimmunoconjugate by direct labeling methods.
Nuclear medicine and biology 1994;21(4):649-55.
-
1994: Shih L B; Thorpe S R; Griffiths G L; Diril H; Ong G L; Hansen H J; Goldenberg D M; Mattes M J
The processing and fate of antibodies and their radiolabels bound to the surface of tumor cells in vitro: a comparison of nine radiolabels.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1994;35(5):899-908.
-
1994: Becker W; Goldenberg D M; Wolf F
The use of monoclonal antibodies and antibody fragments in the imaging of infectious lesions.
Seminars in nuclear medicine 1994;24(2):142-53.
-
1994: Shih L B; Goldenberg D M; Xuan H; Lu H W; Mattes M J; Hall T C
Internalization of an intact doxorubicin immunoconjugate.
Cancer immunology, immunotherapy : CII 1994;38(2):92-8.
-
1994: Sharkey R M; Goldenberg D M; Vagg R; Pawlyk D; Wong G Y; Siegel J A; Murthy S; Levine G M; Izon D; Gascon P
Phase I clinical evaluation of a new murine monoclonal antibody (Mu-9) against colon-specific antigen-p for targeting gastrointestinal carcinomas.
Cancer 1994;73(3 Suppl):864-77.
-
1994: Stein R; Blumenthal R; Sharkey R M; Goldenberg D M
Comparative biodistribution and radioimmunotherapy of monoclonal antibody RS7 and its F(ab')2 in nude mice bearing human tumor xenografts.
Cancer 1994;73(3 Suppl):816-23.
-
1994: Mattes M J; Griffiths G L; Diril H; Goldenberg D M; Ong G L; Shih L B
Processing of antibody-radioisotope conjugates after binding to the surface of tumor cells.
Cancer 1994;73(3 Suppl):787-93.
-
1994: Griffiths G L; Goldenberg D M; Diril H; Hansen H J
Technetium-99m, rhenium-186, and rhenium-188 direct-labeled antibodies.
Cancer 1994;73(3 Suppl):761-8.
-
1994: Blumenthal R D; Sharkey R M; Forman D; Wong G; Goldenberg D M
Cytokine intervention permits dose escalation of radioantibody. An analysis of myelostimulation by bolus versus continuous infusion of IL-1/GM-CSF.
Cancer 1994;73(3 Suppl):1083-92.
-
1994: Shih L B; Lu H H; Xuan H; Goldenberg D M
Internalization and intracellular processing of an anti-B-cell lymphoma monoclonal antibody, LL2.
International journal of cancer. Journal international du cancer 1994;56(4):538-45.
-
1994: Losman M J; Novick K E; Goldenberg D M; Monestier M
Mimicry of a carcinoembryonic antigen epitope by a rat monoclonal anti-idiotype antibody.
International journal of cancer. Journal international du cancer 1994;56(4):580-4.
-
1994: Goldenberg D M
New developments in monoclonal antibodies for cancer detection and therapy.
CA: a cancer journal for clinicians 1994;44(1):43-64.
-
1994: Blumenthal R D; Sharkey R M; Natale A M; Kashi R; Wong G; Goldenberg D M
Comparison of equitoxic radioimmunotherapy and chemotherapy in the treatment of human colonic cancer xenografts.
Cancer research 1994;54(1):142-51.
-
1993: Stein R; Basu A; Chen S; Shih L B; Goldenberg D M
Specificity and properties of MAb RS7-3G11 and the antigen defined by this pancarcinoma monoclonal antibody.
International journal of cancer. Journal international du cancer 1993;55(6):938-46.
-
1993: Stein R; Belisle E; Hansen H J; Goldenberg D M
Epitope specificity of the anti-(B cell lymphoma) monoclonal antibody, LL2.
Cancer immunology, immunotherapy : CII 1993;37(5):293-8.
-
1993: Leung S O; Dion A S; Pellegrini M C; Goldenberg D M; Hansen H J
An extended primer set for PCR amplification of murine kappa variable regions.
BioTechniques 1993;15(2):286-92.
-
1993: Hansen H J; Goldenberg D M; Newman E S; Grebenau R; Sharkey R M
Characterization of second-generation monoclonal antibodies against carcinoembryonic antigen.
Cancer 1993;71(11):3478-85.
-
1993: Goldenberg D M
Monoclonal antibodies in cancer detection and therapy.
The American journal of medicine 1993;94(3):297-312.
-
1993: Sharkey R M; Goldenberg D M; Murthy S; Pinsky H; Vagg R; Pawlyk D; Siegel J A; Wong G Y; Gascon P; Izon D O
Clinical evaluation of tumor targeting with a high-affinity, anticarcinoembryonic-antigen-specific, murine monoclonal antibody, MN-14.
Cancer 1993;71(6):2082-96.
-
1993: Goldenberg D M; Schlom J
The coming of age of cancer radioimmunoconjugates.
Immunology today 1993;14(1):5-7.
-
1993: Goldenberg D M; Wlodkowski T J; Sharkey R M; Silberstein E B; Serafini A N; Garty I I; Van Heertum R L; Higginbotham-Ford E A; Kotler J A; Balasubramanian N
Colorectal cancer imaging with iodine-123-labeled CEA monoclonal antibody fragments.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1993;34(1):61-70.
-
1992: Blumenthal R D; Sharkey R M; Haywood L; Natale A M; Wong G Y; Siegel J A; Kennel S J; Goldenberg D M
Targeted therapy of athymic mice bearing GW-39 human colonic cancer micrometastases with 131I-labeled monoclonal antibodies.
Cancer research 1992;52(21):6036-44.
-
1992: Goldenberg D M
Cancer imaging with CEA antibodies: historical and current perspectives.
The International journal of biological markers 1992;7(3):183-8.
-
1992: Blumenthal R D; Sharkey R M; Kashi R; Natale A M; Goldenberg D M
Physiological factors influencing radioantibody uptake: a study of four human colonic carcinomas.
International journal of cancer. Journal international du cancer 1992;51(6):935-41.
-
1992: Grebenau R C; Goldenberg D M; Chang C H; Koch G A; Gold D V; Kunz A; Hansen H J
Microheterogeneity of a purified IgG1 due to asymmetric Fab glycosylation.
Molecular immunology 1992;29(6):751-8.
-
1992: Boerman O C; Sharkey R M; Blumenthal R D; Aninipot R L; Goldenberg D M
The presence of a concomitant bulky tumor can decrease the uptake and therapeutic efficacy of radiolabeled antibodies in small tumors.
International journal of cancer. Journal international du cancer 1992;51(3):470-5.
-
1992: Goldenberg D M; Larson S M
Radioimmunodetection in cancer identification.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1992;33(5):803-14.
-
1992: Sharkey R M; Boerman O C; Natale A; Pawlyk D; Monestier M; Losman M J; Goldenberg D M
Enhanced clearance of radiolabeled murine monoclonal antibody by a syngeneic anti-idiotype antibody in tumor-bearing nude mice.
International journal of cancer. Journal international du cancer 1992;51(2):266-73.
-
1992: Kyriakos R J; Shih L B; Ong G L; Patel K; Goldenberg D M; Mattes M J
The fate of antibodies bound to the surface of tumor cells in vitro.
Cancer research 1992;52(4):835-42.
-
1992: Fand I; Sharkey R M; Grundy J P; Goldenberg D M
Localization by whole-body autoradiography of intact and fragmented radiolabeled antibodies in a metastatic human colonic cancer model.
International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology 1992;19(1):87-99.
-
1992: Stein R; Sharkey R M; Goldenberg D M
Haematological effects of radioimmunotherapy in cancer patients.
British journal of haematology 1992;80(1):69-76.
-
1992: Murthy S; Sharkey R M; Goldenberg D M; Lee R E; Pinsky C M; Hansen H J; Burger K; Swayne L C
Lymphoma imaging with a new technetium-99m labelled antibody, LL2.
European journal of nuclear medicine 1992;19(6):394-401.
-
1992: Boerman O C; Sharkey R M; Wong G Y; Blumenthal R D; Aninipot R L; Goldenberg D M
Influence of antibody protein dose on therapeutic efficacy of radioiodinated antibodies in nude mice bearing GW-39 human tumor.
Cancer immunology, immunotherapy : CII 1992;35(2):127-34.
-
1991: Goldenberg D M
Imaging and therapy of gastrointestinal cancers with radiolabeled antibodies.
The American journal of gastroenterology 1991;86(10):1392-403.
-
1991: Shih L B; Goldenberg D M; Xuan H; Lu H; Sharkey R M; Hall T C
Anthracycline immunoconjugates prepared by a site-specific linkage via an amino-dextran intermediate carrier.
Cancer research 1991;51(16):4192-8.
-
1991: Sharkey R M; Natale A; Goldenberg D M; Mattes M J
Rapid blood clearance of immunoglobulin G2a and immunoglobulin G2b in nude mice.
Cancer research 1991;51(12):3102-7.
-
1991: Sharkey R M; Weadock K S; Natale A; Haywood L; Aninipot R; Blumenthal R D; Goldenberg D M
Successful radioimmunotherapy for lung metastasis of human colonic cancer in nude mice.
Journal of the National Cancer Institute 1991;83(9):627-32.
-
1991: Goldenberg D M; Horowitz J A; Sharkey R M; Hall T C; Murthy S; Goldenberg H; Lee R E; Stein R; Siegel J A; Izon D O
Targeting, dosimetry, and radioimmunotherapy of B-cell lymphomas with iodine-131-labeled LL2 monoclonal antibody.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1991;9(4):548-64.
-
1991: Losman M J; Hansen H J; Sharkey R M; Goldenberg D M; Monestier M
Human response against NP-4, a mouse antibody to carcinoembryonic antigen: human anti-idiotype antibodies mimic an epitope on the tumor antigen.
Proceedings of the National Academy of Sciences of the United States of America 1991;88(8):3421-5.
-
1991: Stein R; Wang Z F; Sharkey R M; Klein K M; Goldenberg D M
A new murine monoclonal antibody against human hepatoma.
Hybridoma 1991;10(2):255-67.
-
1991: Ong G L; Ettenson D; Sharkey R M; Marks A; Baumal R; Goldenberg D M; Mattes M J
Galactose-conjugated antibodies in cancer therapy: properties and principles of action.
Cancer research 1991;51(6):1619-26.
-
1991: Stein R; Goldenberg D M; Mattes M J
Normal tissue reactivity of four anti-tumor monoclonal antibodies of clinical interest.
International journal of cancer. Journal international du cancer 1991;47(2):163-9.
-
1991: Blumenthal R D; Kashi R; Stephens R; Sharkey R M; Goldenberg D M
Improved radioimmunotherapy of colorectal cancer xenografts using antibody mixtures against carcinoembryonic antigen and colon-specific antigen-p.
Cancer immunology, immunotherapy : CII 1991;32(5):303-10.
-
1991: Blumenthal R D; Sharkey R M; Kashi R; Goldenberg D M
Suppression of tumor vascular activity by radioantibody therapy: implications for multiple cycle treatments.
Selective cancer therapeutics 1991;7(1):9-16.
-
1991: Goldenberg D M
Cancer imaging and therapy with radiolabeled antibodies.
Advances in experimental medicine and biology 1991;303():107-17.
-
1991: Blumenthal R D; Fand I; Sharkey R M; Boerman O C; Kashi R; Goldenberg D M
The effect of antibody protein dose on the uniformity of tumor distribution of radioantibodies: an autoradiographic study.
Cancer immunology, immunotherapy : CII 1991;33(6):351-8.
-
1991: Motta-Hennessy C; Sharkey R M; Goldenberg D M
Labeling of monoclonal antibody conjugates with 90Y.
International journal of radiation applications and instrumentation. Part A, Applied radiation and isotopes 1991;42(5):421-6.
-
1990: Shih L B; Xuan H; Sharkey R M; Goldenberg D M
A fluorouridine-anti-CEA immunoconjugate is therapeutically effective in a human colonic cancer xenograft model.
International journal of cancer. Journal international du cancer 1990;46(6):1101-6.
-
1990: Goldenberg D M; Sharkey R M; Goldenberg H; Hall T C; Murthy S; Izon D O; Gascon P; Swayne L C
Monoclonal antibody therapy of cancer.
New Jersey medicine : the journal of the Medical Society of New Jersey 1990;87(11 Spec No):913-8.
-
1990: Motta-Hennessy C; Sharkey R M; Goldenberg D M
Metabolism of indium-111-labeled murine monoclonal antibody in tumor and normal tissue of the athymic mouse.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1990;31(9):1510-9.
-
1990: Losman M J; Monestier M; Hansen H J; Goldenberg D M
Baboon anti-idiotype antibodies mimic a carcinoembryonic antigen epitope.
International journal of cancer. Journal international du cancer 1990;46(2):310-4.
-
1990: Sharkey R M; Goldenberg D M; Goldenberg H; Lee R E; Ballance C; Pawlyk D; Varga D; Hansen H J
Murine monoclonal antibodies against carcinoembryonic antigen: immunological, pharmacokinetic, and targeting properties in humans.
Cancer research 1990;50(9):2823-31.
-
1990: Weadock K S; Sharkey R M; Varga D C; Goldenberg D M
Evaluation of a remote radioiodination system for radioimmunotherapy.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1990;31(4):508-11.
-
1990: Sharkey R M; Motta-Hennessy C; Pawlyk D; Siegel J A; Goldenberg D M
Biodistribution and radiation dose estimates for yttrium- and iodine-labeled monoclonal antibody IgG and fragments in nude mice bearing human colonic tumor xenografts.
Cancer research 1990;50(8):2330-6.
-
1990: Blumenthal R D; Sharkey R M; Quinn L M; Goldenberg D M
Use of hematopoietic growth factors to control myelosuppression caused by radioimmunotherapy.
Cancer research 1990;50(3 Suppl):1003s-1007s.
-
1990: Sharkey R M; Blumenthal R D; Hansen H J; Goldenberg D M
Biological considerations for radioimmunotherapy.
Cancer research 1990;50(3 Suppl):964s-969s.
-
1990: Goldenberg D M; Goldenberg H; Sharkey R M; Higginbotham-Ford E; Lee R E; Swayne L C; Burger K A; Tsai D; Horowitz J A; Hall T C
Clinical studies of cancer radioimmunodetection with carcinoembryonic antigen monoclonal antibody fragments labeled with 123I or 99mTc.
Cancer research 1990;50(3 Suppl):909s-921s.
-
1990: Fand I; Sharkey R M; Goldenberg D M
Use of whole-body autoradiography in cancer targeting with radiolabeled antibodies.
Cancer research 1990;50(3 Suppl):885s-891s.
-
1990: Mattes M J; Major P P; Goldenberg D M; Dion A S; Hutter R V; Klein K M
Patterns of antigen distribution in human carcinomas.
Cancer research 1990;50(3 Suppl):880s-884s.
-
1990: Sharkey R M; Gold D V; Aninipot R; Vagg R; Ballance C; Newman E S; Ostella F; Hansen H J; Goldenberg D M
Comparison of tumor targeting in nude mice by murine monoclonal antibodies directed against different human colorectal cancer antigens.
Cancer research 1990;50(3 Suppl):828s-834s.
-
1990: Hansen H J; Jones A L; Sharkey R M; Grebenau R; Blazejewski N; Kunz A; Buckley M J; Newman E S; Ostella F; Goldenberg D M
Preclinical evaluation of an "instant" 99mTc-labeling kit for antibody imaging.
Cancer research 1990;50(3 Suppl):794s-798s.
-
1990: Losman M J; DeJager R L; Monestier M; Sharkey R M; Goldenberg D M
Human immune response to anti-carcinoembryonic antigen murine monoclonal antibodies.
Cancer research 1990;50(3 Suppl):1055s-1058s.
-
1990: Siegel J A; Pawlyk D A; Lee R E; Sasso N L; Horowitz J A; Sharkey R M; Goldenberg D M
Tumor, red marrow, and organ dosimetry for 131I-labeled anti-carcinoembryonic antigen monoclonal antibody.
Cancer research 1990;50(3 Suppl):1039s-1042s.
-
1990: Stein R; Chen S; Sharkey R M; Goldenberg D M
Murine monoclonal antibodies raised against human non-small cell carcinoma of the lung: specificity and tumor targeting.
Cancer research 1990;50(4):1330-6.
-
1990: Stein R; Sharkey R M; Goldenberg D M
Monoclonal antibody targeting of human non-small cell carcinoma of the lung.
Cancer research 1990;50(3 Suppl):866s-868s.
-
1990: Wang Z F; Stein R; Sharkey R M; Goldenberg D M
Carcinoembryonic antigen and alpha-fetoprotein expression and monoclonal antibody targeting in a human hepatoma/nude mouse model.
Cancer research 1990;50(3 Suppl):869s-872s.
-
1990: Goldenberg D M; Goldenberg H; Sharkey R M; Lee R E; Horowitz J A; Hall T C; Hansen H J
In-vivo antibody imaging for the detection of human tumors.
Cancer treatment and research 1990;51():273-92.
-
1990: Hansen H J; Jones A L; Grebenau R; Kunz A; Goldenberg D M
Labeling of anti-tumor antibodies and antibody fragments with Tc-99m.
Cancer treatment and research 1990;51():233-44.
-
1990: Shih L B; Goldenberg D M
Effects of methotrexate-carcinoembryonic-antigen-antibody immunoconjugates on GW-39 human tumors in nude mice.
Cancer immunology, immunotherapy : CII 1990;31(4):197-201.
-
1989: Blumenthal R D; Sharkey R M; Kashi R; Natale A M; Goldenberg D M
Influence of animal host and tumor implantation site on radio-antibody uptake in the GW-39 human colonic cancer xenograft.
International journal of cancer. Journal international du cancer 1989;44(6):1041-7.
-
1989: Goldenberg D M
Future role of radiolabeled monoclonal antibodies in oncological diagnosis and therapy.
Seminars in nuclear medicine 1989;19(4):332-9.
-
1989: Goldenberg D M; Goldenberg H; Sharkey R M; Lee R E; Higgenbotham-Ford E; Horowitz J A; Hall T C; Pinsky C M; Hansen H J
Imaging of colorectal carcinoma with radiolabeled antibodies.
Seminars in nuclear medicine 1989;19(4):262-81.
-
1989: Blumenthal R D; Sharkey R M; Kashi R; Goldenberg D M
Comparison of therapeutic efficacy and host toxicity of two different 131I-labelled antibodies and their fragments in the GW-39 colonic cancer xenograft model.
International journal of cancer. Journal international du cancer 1989;44(2):292-300.
-
1989: Newman E S; Moskie L A; Duggal R N; Goldenberg D M; Hansen H J
Murine monoclonal antibody adsorbed onto vinylidene fluoride floccules used to eliminate antibody interference in "sandwich"-type immunoassays.
Clinical chemistry 1989;35(8):1743-6.
-
1989: Blumenthal R D; Sharkey R M; Snyder D; Goldenberg D M
Reduction by anti-antibody administration of the radiotoxicity associated with 131I-labeled antibody to carcinoembryonic antigen in cancer radioimmunotherapy.
Journal of the National Cancer Institute 1989;81(3):194-9.
-
1989: Monestier M; Debbas M E; Goldenberg D M
Syngeneic anti-idiotype monoclonal antibodies to murine anticarcinoembryonic antigen monoclonal antibodies.
Cancer research 1989;49(1):123-6.
-
1989: Hansen H J; LaFontaine G; Newman E S; Schwartz M K; Malkin A; Mojzisik K; Martin E W; Goldenberg D M
Solving the problem of antibody interference in commercial "sandwich"-type immunoassays of carcinoembryonic antigen.
Clinical chemistry 1989;35(1):146-51.
-
1989: Stein R; Chen S; Grossman W; Goldenberg D M
Human lung carcinoma monoclonal antibody specific for the Thomsen-Friedenreich antigen.
Cancer research 1989;49(1):32-7.
-
1989: Goldenberg D M
Imaging and therapy of cancer with radiolabeled monoclonal antibodies.
Progress in clinical and biological research 1989;288():413-27.
-
1989: Siegel J A; Lee R E; Pawlyk D A; Horowitz J A; Sharkey R M; Goldenberg D M
Sacral scintigraphy for bone marrow dosimetry in radioimmunotherapy.
International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology 1989;16(6):553-9.
-
1988: Stein R; Goldenberg D M
A murine monoclonal antibody raised against human non-small cell carcinoma of the lung.
Hybridoma 1988;7(6):555-67.
-
1988: Blumenthal R D; Sharkey R M; Snyder D J; Hansen H J; Goldenberg D M
Reduction of radioantibody-induced myelotoxicity in hamsters by recombinant interleukin-1.
Cancer research 1988;48(19):5403-6.
-
1988: Traub U C; DeJager R L; Primus F J; Losman M; Goldenberg D M
Antiidiotype antibodies in cancer patients receiving monoclonal antibody to carcinoembryonic antigen.
Cancer research 1988;48(14):4002-6.
-
1988: Sharkey R M; Kaltovich F A; Shih L B; Fand I; Govelitz G; Goldenberg D M
Radioimmunotherapy of human colonic cancer xenografts with 90Y labeled monoclonal antibodies to carcinoembryonic antigen.
Cancer research 1988;48(11):3270-5.
-
1988: Goldenberg D M
Targeting of cancer with radiolabeled antibodies. Prospects for imaging and therapy.
Archives of pathology & laboratory medicine 1988;112(6):580-7.
-
1988: Shih L B; Sharkey R M; Primus F J; Goldenberg D M
Site-specific linkage of methotrexate to monoclonal antibodies using an intermediate carrier.
International journal of cancer. Journal international du cancer 1988;41(6):832-9.
-
1988: Tu Y Y; Primus F J; Goldenberg D M
Temperature affects binding of murine monoclonal IgG antibodies to protein A.
Journal of immunological methods 1988;109(1):43-7.
-
1988: Sharkey R M; Primus F J; Shochat D; Goldenberg D M
Comparison of tumor targeting of mouse monoclonal and goat polyclonal antibodies to carcinoembryonic antigen in the GW-39 human tumor-hamster host model.
Cancer research 1988;48(7):1823-8.
-
1988: Sharkey R M; Mabus J; Goldenberg D M
Factors influencing anti-antibody enhancement of tumor targeting with antibodies in hamsters with human colonic tumor xenografts.
Cancer research 1988;48(8):2005-9.
-
1988: Primus F J; Kelley E A; Hansen H J; Goldenberg D M
"Sandwich"-type immunoassay of carcinoembryonic antigen in patients receiving murine monoclonal antibodies for diagnosis and therapy.
Clinical chemistry 1988;34(2):261-4.
-
1988: Tu Y Y; Primus F J; Shochat D; Goldenberg D M
Purification and characterization of carcinoembryonic antigen from GW-39, a xenografted human colonic tumor system.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 1988;9(4):212-20.
-
1987: Sharkey R M; Pykett M J; Siegel J A; Alger E A; Primus F J; Goldenberg D M
Radioimmunotherapy of the GW-39 human colonic tumor xenograft with 131I-labeled murine monoclonal antibody to carcinoembryonic antigen.
Cancer research 1987;47(21):5672-7.
-
1987: Nocera M A; Shochat D; Primus F J; Krupey J; Jespersen D L; Goldenberg D M
Representation of epitopes on colon-specific antigen-p defined by monoclonal antibodies.
Journal of the National Cancer Institute 1987;79(5):943-8.
-
1987: Goldenberg D M; Goldenberg H; Higginbotham-Ford E; Shochat D; Ruoslahti E
Imaging of primary and metastatic liver cancer with 131I monoclonal and polyclonal antibodies against alphafetoprotein.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1987;5(11):1827-35.
-
1987: Goldenberg D M; Sharkey R M; Ford E
Anti-antibody enhancement of iodine-131 anti-CEA radioimmunodetection in experimental and clinical studies.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1987;28(10):1604-10.
-
1983: Gold D V; Shochat D; Primus F J; Dexter D L; Calabresi P; Goldenberg D M
Differential expression of tumor-associated antigens in human colon carcinomas xenografted into nude mice.
Journal of the National Cancer Institute 1983;71(1):117-24.
-
1982: Shochat D; Pant K D; Goldenberg D M
Colon-specific antigen-p (CSAp). II. Further characterization in colorectal and pancreatic cancer.
Cancer 1982;50(5):927-31.
-
1982: Pant K D; Shochat D; Nelson M O; Goldenberg D M
Colon-specific antigen-p (CSAp). I. Initial clinical evaluation as a marker for colorectal cancer.
Cancer 1982;50(5):919-26.
-
1981: Shochat D; Archey R L; Pant K D; Dahlman H L; Gold D V; Goldenberg D M
Characterization of colon-specific antigen-p and isolation of immunologically active tryptic peptides.
Journal of immunology (Baltimore, Md. : 1950) 1981;126(6):2284-9.
-
1981: Gaffar S A; Pant K D; Shochat D; Bennett S J; Goldenberg D M
Experimental studies of tumor radioimmunodetection using antibody mixtures against carcinoembryonic antigen (CEA) and colon-specific antigen-p (CSAp).
International journal of cancer. Journal international du cancer 1981;27(1):101-5.
Sign-in to see more